Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study (Q43775584)
Jump to navigation
Jump to search
scientific article published on 8 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study |
scientific article published on 8 October 2012 |
Statements
1 reference
Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study (English)
1 reference
B Zegels
1 reference
P Crozes
1 reference
D Uebelhart
1 reference
O Bruyère
1 reference
J Y Reginster
1 reference
8 October 2012
1 reference
1 reference
21
1 reference
1
1 reference
22-27
1 reference
Identifiers
1 reference
1 reference